Tinuade Awe, the CEO of NGX Regulation Limited (NGX REGCO), the independent regulatory subsidiary of the Nigerian Exchange Group (NGX), has left the group.
Ms. Awe joined the Nigerian Stock Exchange (NSE), now known as the NGX Group, as a consultant in August 2010. She later became a member of the NSE's Executive Committee, holding a number of roles including Board Secretary and General Counsel, before becoming Executive Director for Regulation in January 2018.
She was appointed CEO of NGX REGCO following the demutualisation of the NSE in 2021. NGX REGCO aims to “[promote] just and equitable principles of trade and sound business practices in the Nigerian capital market.” The NGX Group also includes two other subsidiaries namely Nigerian Exchange Limited (NGX Exchange) and NGX Real Estate Limited (NGX RELCO).
In a brief statement to Capital Markets Africa, Ms. Awe said she was exploring new opportunities "whilst getting some rest over the next few months."
Last month, Ms. Awe was appointed to the global supervisory board of the Global Reporting Initiative (GRI), an international independent standards body that helps global businesses and governments improve their reporting around climate, human rights, and corruption issues.
In 2023, she became an independent director of Lily Hospitals Limited, a private Nigerian healthcare provider. CarePoint, the investment holding company of US-Ghanaian entrepreneur Sangu Delle, is one of its investors.
© Capital Markets Africa, 2024
Founded by journalist Chipo Muwowo, Capital Markets Africa aims to raise the profile of African listed companies. Whether you're a retail or institutional investor, based in Africa or outside, we want you to be better educated about the investment opportunity set and the broader African equities market ecosystem. Subscribe today!
Discussion about this post
No posts